{
    "2018-07-26": [
        [
            {
                "time": "",
                "original_text": "【国信医药|2018年中报业绩前瞻】分化加剧，寻找确定性增长",
                "features": {
                    "keywords": [
                        "国信医药",
                        "2018年中报",
                        "业绩前瞻",
                        "分化加剧",
                        "确定性增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "同事眼中的高俊芳:从朴素漂亮 到看不懂的\"疫苗女王\"",
                "features": {
                    "keywords": [
                        "高俊芳",
                        "疫苗女王",
                        "同事评价"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "生物医药板块行情 明显分化",
                "features": {
                    "keywords": [
                        "生物医药",
                        "板块行情",
                        "明显分化"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "解码百元股 逾九成业绩向好",
                "features": {
                    "keywords": [
                        "百元股",
                        "业绩向好",
                        "解码"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}